How much is the price of atezolizumab subcutaneous preparation (TECENTRIQ HYBREZA), how to buy it and identify the authenticity

Atezolizumab subcutaneous preparation is an anti-tumor drug developed based on the immune checkpoint blocking mechanism. It is suitable for the systemic treatment of various cancers, such as non-small cell lung cancer, small cell lung cancer, hepatocellular carcinoma and melanoma. As a subcutaneous version of atezolizumab, the drug uses a hyaluronidase excipient to support rapid absorption of large volumes of drug solution, thereby simplifying the dosing process while maintaining efficacy. At present, this preparation has been approved for marketing in the United States and other countries, but it has not yet been officially registered in mainland China. Therefore, its price, purchase method and authenticity identification have become issues of widespread concern to patients.

According to foreign public channels, the international market price of atezolizumab subcutaneous preparations is usually measured in units of 15 ml per tube, and the price of a single dose is approximately US$4,000 to US$6,000. The specific cost varies depending on national policies and drug distribution channels. As it has not yet been included in China's medical insurance catalog, the use of this drug is at one's own expense, and the overall treatment cost is relatively high. Some areas will also charge for cold chain transportation, prescription translation or pharmaceutical services, further affecting the total price.

Since this preparation is not approved in China, if patients need to use it, they can obtain it through two legal ways. One is to go abroad for treatment, and a qualified medical institution will issue a prescription and complete the entire management process. The second is to assist third-party agencies with overseas pharmaceutical service licenses and distribute them to China through cold chain methods. No matter which method is chosen, patients should complete the evaluation under the guidance of a professional doctor and ensure that the source of the medicine is formal.

In the actual purchase process, identifying the authenticity of drugs is an important step in ensuring drug safety. First of all, it should be ensured that the drugs are provided by legally registered pharmacies or qualified pharmaceutical supply institutions, and can issue complete drug batch numbers and original English packaging. Secondly, the outer packaging of genuine drugs should be clearly printed and well sealed, and the bottle should have batch information and expiry date labels. Patients can also check the batch number information through the official website of the drug's origin or the anti-counterfeiting platform provided by the regulatory agency. When necessary, entrust a doctor or pharmacist to review the appearance, cold chain records and instructions of the drug.

It is worth noting that the subcutaneous preparation of atezolizumab needs to be stored in an environment of 2 to 8 degrees Celsius. It cannot be frozen, exposed to strong light or violently shaken. The entire cold chain management must be carried out during drug transportation. After receiving the medicine, you should immediately check whether the packaging is intact and whether the transportation temperature control records are abnormal. If drug leakage, damaged labels or temperature alarm records are found, use should be stopped immediately and the supplier should be contacted for processing.

To sum up, the subcutaneous preparation of atezolizumab is not yet on the market in China, the price is relatively high, and the drug purchase channels are mainly from overseas compliance agencies. Before actual use, it is necessary to complete a medical evaluation, strictly verify the source of the drug, and check the authenticity of the drug through a formal platform to ensure the safety and compliance of the treatment.

Reference materials:https://www.drugs.com/search.php?searchterm=TECENTRIQ+HYBREZA